Novel Selective Quinazoline Inhibitors of Endothelin Converting Enzyme-1
- 4 February 1998
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 243 (1), 184-190
- https://doi.org/10.1006/bbrc.1998.8081
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cellsLife Sciences, 1995
- ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1Cell, 1994
- Mammalian Paired Basic Amino Acid Convertases of Prohormones and ProproteinsAnnals of the New York Academy of Sciences, 1993
- The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Inhibition of biological actions of big endothelin-1 by phosphoramidonBiochemical and Biophysical Research Communications, 1990
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymeBiochemical and Biophysical Research Communications, 1990
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1European Journal of Pharmacology, 1990
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences of the United States of America, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988